𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1-30-16 Cardiovascular safety of entacapone in the treatment of patients with Parkinson's disease (PD)

✍ Scribed by J. Lyytinen; S. Kaakkola; A. Gordin; H. Teräväinen

Book ID
119469107
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
179 KB
Volume
150
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of entacapone, a COMT inhibitor,
Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease
✍ V. V. Myllylä; K. A. Sotaniemi; A. Illi; K. Suominen; T. Keränen 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 563 KB

In an open, randomised, cross-over study we investigated the effect of a single 200 mg oral dose of entacapone, a novel catechol-O-methyltransferase (COMT) inhibitor, on the pharmacokinetics and metabolism of levodopa/carbidopa, and on the cardiovascular responses (blood pressure and pulse rate vari